APPLICATION
ANDA074305
TYPE
ANDA
ORIGINAL APPROVAL
1995-04-07
LATEST ACTION
2017-04-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
GLIPIZIDEDiscontinued
GLIPIZIDE 5MG · TABLET · ORAL
GLIPIZIDEDiscontinued
GLIPIZIDE 10MG · TABLET · ORAL
Approval history
2017-04-11Labeling · Supplement 30 · standardAP
2017-04-11Labeling · Supplement 27 · standardAP
2013-07-26Labeling · Supplement 24AP
2009-05-19Labeling · Supplement 23AP
2002-04-19Manufacturing (CMC) · Supplement 11AP
2002-03-25Manufacturing (CMC) · Supplement 12AP
2001-12-05Manufacturing (CMC) · Supplement 8AP
2001-09-21Manufacturing (CMC) · Supplement 9AP
2001-08-09Labeling · Supplement 10AP
2000-12-13Manufacturing (CMC) · Supplement 7AP
2000-11-30Manufacturing (CMC) · Supplement 6AP
1999-12-17Labeling · Supplement 5AP
1999-02-01Labeling · Supplement 3AP
1999-02-01Manufacturing (CMC) · Supplement 2AP
1996-10-22Manufacturing (CMC) · Supplement 1AP
1995-04-07OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.